FDA Inspection 1314218 — Tissuegenx LLC
The FDA completed an inspection of Tissuegenx LLC on April 20, 2026 in Roswell, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 20, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Roswell, GA (United States)